期刊文献+

不同免疫方式对新冠DNA疫苗应答效果的影响 被引量:2

The effect of different immunization routes on the response of SARS-CoV-2 DNA vaccine
下载PDF
导出
摘要 目的探究气管灌注和电脉冲肌肉导入2种免疫方式对新型冠状病毒(SARS-CoV-2)DNA疫苗免疫应答的影响。方法利用真核表达载体pVAX-1,设计并构建p RBD、p S-2P和p S-2P.3513种SARS-CoV-2 DNA疫苗。在第0、2和4周采用气管灌注以及电脉冲肌肉导入2种方式免疫小鼠。末次免疫后2周,ELISA检测血清及阴道灌洗液特异性IgG抗体水平,肺泡灌洗液(bronchoalveolar lavage fluid,BALF)、鼻腔灌洗液(nasal solution,NS)以及阴道灌洗液(vaginal wash)特异性sIgA抗体水平;ELISpot检测免疫后小鼠脾细胞分泌特异性IFN-gamma的水平。结果气管灌注及电脉冲肌肉导入2种方式免疫SARS-CoV-2DNA疫苗,仅气管灌注免疫可诱导特异性呼吸道黏膜sIgA应答,而电脉冲肌肉导入诱导了更强的细胞免疫应答。与气管灌注pRBD相比,气管灌注pS-2P和p S-2P.351可诱导更强的黏膜免疫应答和细胞免疫应答。结论气管灌注和电脉冲肌肉导入2种免疫方式均可诱导特异性体液免疫以及细胞免疫应答,电脉冲肌肉导入诱导了更强的细胞免疫应答,而气管灌注在诱导呼吸道黏膜免疫应答方面更具优势。 To explore the effects of two immunization routes,intratracheal(i.t.)immunization and intramuscular injection with electroporation(i.m.+EP),on the immune response of the SARS-CoV-2 DNA vaccine,three SARSCoV-2 DNA vaccines pRBD,pS-2 P and pS-2 P.351 were designed and constructed by using eukaryotic expression vector pVAX-1.The mice were immunized by intratracheal instillation or intramuscular injection with electroporation at 0,2 and 4 weeks.The level of specific IgG in serum and vaginal lavage fluid,and the level of specific sIgA in BALF,nasal solution(NS)and vaginal wash were evaluated;specific IFN-gamma secreted by mouse splenocytes was tested by ELISpot.Data showed only intratracheal immunization could induce specific respiratory mucosal sIgA response,while intramuscular injection with electroporation could induce stronger cellular immune response.Compared with pRBD intratracheal immunization,intratracheal immunization with pS-2P and pS-2P.351 could induce stronger mucosal and cellular immune responses.In conclusion,both intratracheal immunization and intramuscular injection with electroporation could induce specific humoral and cellular immune response.Intramuscular injection with electroporation induces a stronger cellular immune response,and intratracheal immunization has more advantages in inducing respiratory mucosal immune response.
作者 刘畅 李郭成 金喆 薛若怡 刘婧怡 冯壤 金滋力 邹全明 李海波 LIU Chang;LI Guocheng;JIN Zhe;XUE Ruoyi;LIU Jingyi;FENG Rang;JIN Zili;ZOU Quanming;LI Haibo(National Engineering Research Center of Immunological Products&Department of Microbiology and Biochemical Pharmacy,College of Pharmacy,Army Medical University,Chongqing 400038,China)
出处 《免疫学杂志》 CAS CSCD 北大核心 2022年第2期170-176,184,共8页 Immunological Journal
基金 重庆市自然科学基金重点项目(cstc2020jcyjzdxmX0027) 陆军军医大学科技创新能力提升专项(2020XGBD06)
关键词 新型冠状病毒 DNA疫苗 气管灌注 电脉冲肌肉导入 免疫应答 SARS-CoV-2 DNA vaccine Intratracheal immunization Intramuscular injection with electroporation Immune response
  • 相关文献

参考文献1

二级参考文献22

  • 1黄俊,马瑞,吴长有.SARS-CoV S DNA疫苗诱导特异性T细胞及相关细胞因子的特性研究[J].中华微生物学和免疫学杂志,2005,25(11):940-943. 被引量:1
  • 2Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome [J]. N Engl J Med, 2003, 348(20): 1967-1976.
  • 3Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome [J]. Lancet, 2003, 361(9366): 1319-1325.
  • 4See RH, Zakhartchouk AN, Petric M, et al. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus [J]. J Gen Virol, 2006, 87(Pt 3): 641-650.
  • 5Zhang CH, Lu JH, Wang YF, et al. Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain [J]. Vaccine, 2005, 23(24): 3196-3201.
  • 6Guo Y, Sun S, Wang K, et al. Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus [J]. DNA Cell Biol, 2005, 24(8): 510-515.
  • 7Yuen KY, Woo PC, Lau SK. An oral mucosal DNA vaccine for SARS coronavirus infections [J]. Hong Kong Med J, 2009, 15 (Suppl)2: 41-42.
  • 8Lu B, Tao L, Wang T, et al. Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (SARS) or SARS-like coronavirus in mice [J]. Clin Vaccine Immunol, 2009, 16(1): 73-77.
  • 9Martin JE, Louder MK, Holman LA, et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial [J]. Vaccine, 2008, 26(50): 6338-6343.
  • 10Zhao K, Yang B, Xu Y, et al. CD8^+ T cell response in HLA- A*0201 transgenic mice is elicited by epitopes from SARS-CoV S p otem [J]. Vaccrue, 2010, 28(41):6666-6674.

共引文献2

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部